| 摘要 |
The present invention relates to a method for assessing whether a patient subjected to an antigen-specific Trl cell therapy is responding to the treatment, said method comprising: determining in vitro the antigen-specific proliferation of T cells contained in a cell sample from said patient, comparing said antigen-specific proliferation to a standard reference, thereby determining whether the patient is responding or not to the treatment. |
